| 2025-04-03 19:14:00 |
35-year Industry-academic Partnership Yielding Groundbreaking Advances For Science And Patients Renews For Another Three Years Between La Jolla Institute For Immunology And Kyowa Kirin
-agreement extends one of the world’s most enduring alliances for drug discovery- -landmark discoveries from partnership have led to novel drug candidates, including an immunotherapy for moderate to severe atopic dermatitis currently in phase iii clinical trials- - new focus on cell and gene therapies to accelerate novel treatments for patients with unmet medical needs - la jolla, calif. and princeton, n.j. |
| 2025-02-26 08:00:00 |
Kyowa Kirin Announces Late-breaking Abstract Presentation At The American Academy Of Dermatology Annual Meeting 2025
Princeton, n.j. , feb. 26, 2025 /prnewswire/ -- kyowa kirin co., ltd. |
| 2025-01-30 05:05:00 |
Kyowa Kirin And Swixx Biopharma Announce Expansion Of Access To Poteligeo® (mogamulizumab) For Adults Living With Mycosis Fungoides Or SÉzary Syndrome In Central And Eastern Europe
Galashiels & marlow, england & baar, switzerland--(business wire)--kyowa kirin international (kki), a wholly owned subsidiary of kyowa kirin co. ltd., and swixx biopharma ag today announced that the croatian national health insurance fund (nhif) and the bulgarian ministry of health have both approved the reimbursement of poteligeo® (mogamulizumab) for adult patients with mycosis fungoides (mf), and sÉzary syndrome (ss). mf and ss are two subtypes of cutaneous t-cell lymphoma (ctcl), a rare form. |
| 2025-01-28 10:00:00 |
Alphameld Corporation Expands Collaboration With Kyowa Kirin For Enterprise-wide Access To Drug Discovery Platform
Longstanding relationship strengthens innovation, providing diverse stakeholders access to advanced ai-driven insights to accelerate therapeutic discovery and development longstanding relationship strengthens innovation, providing diverse stakeholders access to advanced ai-driven insights to accelerate therapeutic discovery and development |
| 2024-12-09 20:00:00 |
Cimeio Therapeutics Announces Partnership With Kyowa Kirin To Develop Novel Cell Therapies
Basel, switzerland--(business wire)--cimeio therapeutics announced today that it has entered a research collaboration with kyowa kirin co., ltd. (kyowa kirin) to develop a novel therapy for diseases with high unmet need. the partnership combines cimeio’s proprietary shielded-cell & immunotherapy pairs™ (scip) platform with kyowa kirin’s expertise in cellular therapies and underscores both companies’ commitment to using emerging cell and gene therapy technologies to develop new ways to treat. |
| 2024-10-31 02:40:00 |
S3lvd2EgS2 lyaW4gQW5u b3VuY2VzIE NoYW5nZXMg SW4gVG9wIE xlYWRlcnNo aXAgUG9zaX Rpb25zIFRv IFN0cmVuZ3 RoZW4gT3Bl cmF0aW9ucy BBcyBBIEds b2JhbCBTcG VjaWFsdHkg UGhhcm1hY2 V1dGljYWwg Q29tcGFueQ ==
VG9reW8tLS hidXNpbmVz cyB3aXJlKS 0tamFwYW4t YmFzZWQgZ2 xvYmFsIHNw ZWNpYWx0eS BwaGFybWFj ZXV0aWNhbC Bjb21wYW55 IGt5b3dhIG tpcmluIGNv LiwgbHRkLi AocHJlc2lk ZW50IGFuZC BjZW86IG1h c2FzaGkgbW l5YW1vdG8u KSAodG9reW 86NDE1MSkg dG9kYXkgYW 5ub3VuY2Vk IHRoYXQgbW FzYXNoaSBt aXlhbW90by wgcGguZC4g d2lsbCB0YW tlIHRoZSBy b2xlIG9mIG NoYWlybWFu IGFuZCBjZW 8sIGFmdGVy IHNlcnZpbm cgYXMgcHJl c2lkZW50IG ZvciB0aGUg cGFzdCA3IH llYXJzLiBh YmR1bCBtdW xsaWNrLCBw aC5kLiwgdG hlIGN1cnJl bnQgY2hpZW YgaW50ZXJu YXRpb25hbC BidXNpbmVz cyBvZmZpY2 VyIChjaWJv KSwgd2lsbC BiZWNvbWUg cHJlc2lkZW 50IGFuZCBj aGllZiBvcG VyYXRpbmcg b2ZmaWNlci 4gdGhlIGNo YW5nZXMgd2 lsbCBjb21l IGludG8gZW ZmZWN0IGZv bGxvd2luZy BhcHByb3Zh bCBhdCB0aG Ugb3JkaW5h cnkgZ2VuZX JhbCBtZWV0 aW5nLg==
|
| 2024-10-08 03:05:00 |
S3lvd2EgS2 lyaW4gQW5u b3VuY2VzIF Bvc2l0aXZl IEludGVyaW 0gUmVhbC13 b3JsZCBEYX RhIEZvciBN b2dhbXVsaX p1bWFiIChw b3RlbGlnZW /CrikgSW4g Q3V0YW5lb3 VzIFQtY2Vs bCBMeW1waG 9tYSBBdCBF b3J0Yy1jbH RnIDIwMjQ=
R2FsYXNoaW VscyAmIG1h cmxvdywgZW 5nbGFuZC0t KGJ1c2luZX NzIHdpcmUp LS1reW93YS BraXJpbiBp bnRlcm5hdG lvbmFsIChr a2kpLCBhIH dob2xseSBv d25lZCBzdW JzaWRpYXJ5 IG9mIGt5b3 dhIGtpcmlu IGNvLiwgbH RkLiAodHNl OjQxNTEsIG t5b3dhIGtp cmluKSwgdG 9kYXkgYW5u b3VuY2VkIG l0IHdpbGwg cHJlc2VudC BpbnRlcmlt IGZpbmRpbm dzIGZyb20g dGhyZWUgcm VhbC13b3Js ZCBzdHVkaW VzIGluIGN1 dGFuZW91cy B0LWNlbGwg bHltcGhvbW EgKGN0Y2wp IGF0IHRoZS Bhbm51YWwg bWVldGluZy BvZiB0aGUg ZXVyb3BlYW 4gb3JnYW5p c2F0aW9uIG ZvciByZXNl YXJjaCBhbm QgdHJlYXRt ZW50IG9mIG NhbmNlcuKA mXMgY3V0YW 5lb3VzIGx5 bXBob21hIH R1bW91ciBn cm91cCAoZW 9ydGMtY2x0 ZyksIHRha2 luZyBwbGFj ZSBmcm9tID l0aOKAkzEx dGggb2Ygb2 N0b2JlciAy MDI0IGluIG xhdXNhbm5l LCBzd2l0em VybGFuZC4g dGhlIHRocm VlIHN0dWRp ZXMgaW5jbH Uu
|
| 2024-09-19 08:00:00 |
S3lvd2EgS2 lyaW4gVG8g UHJlc2VudC BOZXcgUmVz ZWFyY2ggU3 BvdGxpZ2h0 aW5nIEdsb2 JhbCBFZmZv cnRzIFRvIE FkdmFuY2Ug U2NpZW5jZS BBbmQgUGF0 aWVudCBDYX JlIEluIFgt bGlua2VkIE h5cG9waG9z cGhhdGVtaW EgQXQgQXNi bXIgQW5udW FsIE1lZXRp bmc=
T25lIG9yYW wgcHJlc2Vu dGF0aW9uIG FuZCBuaW5l IHBvc3Rlcn Mgd2lsbCBz aGVkIGxpZ2 h0IG9uIHJl YWwtd29ybG QgZXhwZXJp ZW5jZXMgb2 YgcGVvcGxl IGxpdmluZy B3aXRoIHhs aCBhbmQgdG hlIGltcGFj dCBvZiBidX Jvc3VtYWIg dHJlYXRtZW 50IHRva3lv ICwgc2VwdC 4gMTksIDIw MjQgL3Bybm V3c3dpcmUv IC0tIGt5b3 dhIGtpcmlu IGNvLiwgbH RkLg==
|
| 2024-08-23 11:05:00 |
S3lvd2EgS2 lyaW4gVG8g RW5kIERpc3 RyaWJ1dGlv biBPZiBGYX Jlc3RvbiAo dG9yZW1lZm luZSkgSW4g VGhlIFVuaX RlZCBTdGF0 ZXM=
UHJpbmNldG 9uLMKgbi5q LiwgYXVnLi AyMywgMjAy NCAvcHJuZX dzd2lyZS8g LS0ga3lvd2 Ega2lyaW4s IGluYy4sIG FuIGFmZmls aWF0ZSBvZi BreW93YSBr aXJpbiBjby 4sIGx0ZC4=
|
| 2024-08-07 03:00:00 |
S3lvd2EgS2 lyaW4gSW50 ZXJuYXRpb2 5hbCBBbmQg TmV3YnJpZG dlIFBoYXJt YWNldXRpY2 FscyBFbnRl ciBJbnRvIE FncmVlbWVu dCBUbyBJbX Byb3ZlIEFj Y2VzcyBUby BNZWRpY2lu ZXMgRm9yIF JhcmUgRGlz ZWFzZSBQYX RpZW50cyBB Y3Jvc3MgTW lkZGxlIEVh c3QgQW5kIE 5vcnRoIEFm cmljYQ==
R2FsYXNoaW Vscywgc2Nv dGxhbmQgJi BtYXJsb3cs IGVuZ2xhbm QtLShidXNp bmVzcyB3aX JlKS0ta3lv d2Ega2lyaW 4gaW50ZXJu YXRpb25hbC Aoa2tpKSwg YSB3aG9sbH kgb3duZWQg c3Vic2lkaW FyeSBvZiBr eW93YSBraX JpbiBjby4s IGx0ZC4gKH RzZTo0MTUx LCBreW93YS BraXJpbikg YW5kIGEgam FwYW4tYmFz ZWQgZ2xvYm FsIHNwZWNp YWx0eSBwaG FybWFjZXV0 aWNhbCBjb2 1wYW55LCBh bm5vdW5jZW QgdG9kYXkg dGhlIHNpZ2 5pbmcgb2Yg YSBwcm9tb3 Rpb24gYW5k IGRpc3RyaW J1dGlvbiBh Z3JlZW1lbn Qgd2l0aCBu ZXdicmlkZ2 UgcGhhcm1h Y2V1dGljYW xzIGZvciB0 aGUgZGlzdH JpYnV0aW9u IG9mIGl0cy BleGlzdGlu ZyByYXJlIG Rpc2Vhc2Ug cG9ydGZvbG lvIGFjcm9z cyB0aGUgbW lkZGxlIGVh c3QgYW5kIG 5vcnRoIGFm cmljYSAobW VuYSkuIHVu ZGVyIHRoZS B0ZXJtcyBv ZiB0aGUgYW dyZWVtZW50 LCBuZXdicm lkZ2Ugd2ls bCBjb21tZX JjaWFsaXNl IGNyeS4=
|
| 2024-06-10 07:30:00 |
S3lvd2EgS2 lyaW4gQW5u b3VuY2VzIE JvYXJkIEFw cHJvdmFsIE ZvciBDb25z dHJ1Y3Rpb2 4gT2YgTmV3 IEJpb2xvZ2 ljcyBNYW51 ZmFjdHVyaW 5nIFBsYW50 IEluIFNhbm ZvcmQsIE5j
Q29tcGFuee KAmXMgZmly c3QgbWFudW ZhY3R1cmlu ZyBmYWNpbG l0eSBpbiBu b3J0aCBhbW VyaWNhIHRv IGFjY2VsZX JhdGUgcHJv ZHVjdGlvbi BvZiBuZXcg YmlvbG9naW MgdGhlcmFw aWVzIHRvIG FkdmFuY2Ug Y2xpbmljYW wgcGlwZWxp bmUgZmFjaW xpdHkgdG8g ZHJhdyB1cG 9uIGxvY2Fs IHRhbGVudC wgYXJlYSBj b2xsZWdlcy BhbmQgdW5p dmVyc2l0aW VzIHRvIGZp bGwgbW9yZS B0aGFuIDEw MCBuZXcgcG 9zaXRpb25z IHByaW5jZX Rvbiwgbi5q LsKgLCBqdW 5lIDEwLCAy MDI0IC9wcm 5ld3N3aXJl LyAtLSBreW 93YSBraXJp biwgaW5jLi wgYW4gYWZm aWxpYXRlIG 9mIGt5b3dh IGtpcmluIG NvLiwgbHRk Lg==
|
| 2024-05-08 17:30:00 |
S3lvd2EgS2 lyaW4gV2ls bCBQcmVzZW 50IFByZS1j bGluaWNhbC BEYXRhIEF0 IFRoZSBBc3 NvY2lhdGlv biBGb3IgUm VzZWFyY2gg SW4gVmlzaW 9uIEFuZCBP cGh0aGFsbW 9sb2d5IEFu bnVhbCBNZW V0aW5nIDIw MjQ=
UHJpbmNldG 9uLCBuLmou IGFuZCB0b2 t5byAsIG1h eSA4LCAyMD I0IC9wcm5l d3N3aXJlLy AtLcKga3lv d2Ega2lyaW 4gY28uLCBs dGQu
|
| 2024-04-12 09:00:00 |
S3lvd2EgS2 lyaW4gVG8g UHJlc2VudC BBIFNhZmV0 eSBNZXRhLW FuYWx5c2lz IE9mIE5vdX JpYW56wq4g KGlzdHJhZG VmeWxsaW5l KSBBbmQgT3 RoZXIgUGFy a2luc29u4o CZcyBEaXNl YXNlIEFkZC 1vbiBUaGVy YXBpZXM=
UHJpbmNldG 9uLCBuLmou LCBhcHJpbC AxMiwgMjAy NCAvcHJuZX dzd2lyZS8g LS0ga3lvd2 Ega2lyaW4s IGluYy4sIG FuIGFmZmls aWF0ZSBvZi BreW93YSBr aXJpbiBjby 4sIGx0ZC4g KGt5b3dhIG tpcmluLCB0 c2U6IDQxNT EpLCBhIGds b2JhbCBzcG VjaWFsdHkg cGhhcm1hY2 V1dGljYWwg Y29tcGFueS BiYXNlZCBp biBqYXBhbi wgd2lsbCBh bm5vdW5jZS BmaW5kaW5n cyBmcm9tIG FuIHVwZGF0 ZWQgc3lzdG VtYXRpYyBs aXRlcmF0dX JlIHJldmll dyAoc2xyKS BhbmQgbWV0 YS1hbmFseX NpcyBjb21w YXJpbmcgdG hlIHNhZmV0 eSBvZiBub3 VyaWFuesKu IChpc3RyYW RlZnlsbGlu ZSkgaW4gcm VsYXRpb24g dG8gb3RoZX IgbGV2b2Rv cGEgYWRqdW 5jdGl2ZSB0 aGVyYXBpZX MgZm9yIHBh dGllbnRzIH dpdGggcGFy a2luc29u4o CZcyBkaXNl YXNlIChwZC kuMSwyIG5v dXJpYW56IG lzIGFuIGFk ZW5vc2luZS ByZWNlcHRv ciBhbnRhZ2 9uaXN0IHVz ZWQgd2l0aC BsZXZvZG9w YS9jYXJiaW RvcGEgdG8g dHJlYXQgYW R1bHRzIHdp dGggcGQgZX hwZXJpZW5j aW5nIOKAmW 9mZuKAmSBl cGlzb2Rlcy wgdGhlIHJl dHVybiBvZi BwYXJraW5z b27igJlzIH N5bXB0b21z IGJldHdlZW 4gbWVkaWNh dGlvbiBkb3 Nlcy4gdGhl IGZpbmRpbm dzIHdpbGwg YmUgcHJlc2 VudGVkIGF0 IHRoZSBhbW VyaWNhbiBh Y2FkZW15IG 9mIG5ldXJv bG9neSAoYW FuKSAyMDI0 IGFubnVhbC BtZWV0aW5n LCBkdXJpbm cgYSBwb3N0 ZXIgcHJlc2 VudGF0aW9u IG9uIG1vbm RheSwgYXBy aWwgMTUsIG Zyb20gNToz MCDigJMgNj ozMCBwbSBt ZHQu
|
| 2024-04-02 13:15:00 |
S3lvd2EgS2 lyaW4gQW5u b3VuY2VzIE FjY2VwdGFu Y2UgT2YgQW JzdHJhY3Qg Rm9yIFByZX NlbnRhdGlv biBBdCBUaG UgQXNzb2Np YXRpb24gRm 9yIFJlc2Vh cmNoIEluIF Zpc2lvbiBB bmQgT3BodG hhbG1vbG9n eSBBbm51YW wgTWVldGlu ZyAyMDI0
UHJpbmNldG 9uLCBuLmou IGFuZCB0b2 t5byAsIGFw cmlsIDIsID IwMjQgL3By bmV3c3dpcm UvIC0twqBr eW93YSBraX JpbiBjby4s IGx0ZC4=
|
| 2024-03-08 10:00:00 |
S3lvd2EgS2 lyaW4gV2ls bCBQcmVzZW 50IFBoYXNl IDJiIFBvc3 QtaG9jIEFu YWx5c2lzIE FuZCBTeW1w b3NpdW0gQX QgVGhlIEFt ZXJpY2FuIE FjYWRlbXkg T2YgRGVybW F0b2xvZ3kg QW5udWFsIE 1lZXRpbmcg MjAyNA==
UHJpbmNldG 9uLCBuLmou IGFuZCB0b2 t5byAsIG1h cmNoIDgsID IwMjQgL3By bmV3c3dpcm UvIC0tIGt5 b3dhIGtpcm luIGNvLiwg bHRkLg==
|
